Search

everythinglearnresearchcommunity

for

Search:↓

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Baricitinib is a promising treatment for alopecia areata.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Stress can trigger or worsen alopecia areata.

Plica neuropathica can be a sign of schizophrenia and improves with antipsychotic treatment.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Finasteride may increase suicide risk; more research needed.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.